Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Hallett

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nuclear Medicine Communications|June 23, 2004
Quantification in clinical fluorodeoxyglucose positron emission tomographyW A Hallett
Physics in Medicine and Biology|November 4, 2015
Repurposing the Microsoft Kinect for Windows v2 for external head motion tracking for brain PETP J Noonan, J Howard, W A Hallett, et al.
European Journal of Nuclear Medicine|August 16, 2001
Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancerW A Hallett, P K Marsden, B F Cronin, et al.
Prostaglandins|March 1, 1977
Prostaglandins and congeners XIII (1). The synthesis of dl-erythro-16-methoxyprostaglandinsW A Hallett, A Wissner, C V Grudzinskas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2003
Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardiumS F Barrington, J Chambers, W A Hallett, et al.
Oncology Research|January 1, 1996
alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine AL M Greenberger, K I Collins, T Annable, et al.
Journal of Medicinal Chemistry|September 17, 1993
Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitorsR Paul, W A Hallett, J W Hanifin, et al.
Journal of Medicinal Chemistry|November 1, 1985
Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agentsR Paul, J A Brockman, W A Hallett, et al.
Journal of Medicinal Chemistry|April 11, 1990
Preparation of triazolo[1,5-c]pyrimidines as potential antiasthma agentsJ B Medwid, R Paul, J S Baker, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nuclear Medicine Communications|June 23, 2004
Quantification in clinical fluorodeoxyglucose positron emission tomographyW A Hallett
Physics in Medicine and Biology|November 4, 2015
Repurposing the Microsoft Kinect for Windows v2 for external head motion tracking for brain PETP J Noonan, J Howard, W A Hallett, et al.
European Journal of Nuclear Medicine|August 16, 2001
Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancerW A Hallett, P K Marsden, B F Cronin, et al.
Prostaglandins|March 1, 1977
Prostaglandins and congeners XIII (1). The synthesis of dl-erythro-16-methoxyprostaglandinsW A Hallett, A Wissner, C V Grudzinskas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2003
Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardiumS F Barrington, J Chambers, W A Hallett, et al.
Oncology Research|January 1, 1996
alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine AL M Greenberger, K I Collins, T Annable, et al.
Journal of Medicinal Chemistry|September 17, 1993
Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitorsR Paul, W A Hallett, J W Hanifin, et al.
Journal of Medicinal Chemistry|November 1, 1985
Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agentsR Paul, J A Brockman, W A Hallett, et al.
Journal of Medicinal Chemistry|April 11, 1990
Preparation of triazolo[1,5-c]pyrimidines as potential antiasthma agentsJ B Medwid, R Paul, J S Baker, et al.
Pageof 1